James M. DuBois
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James M. DuBois has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Ana S. Iltis
6 shared publications- Heidi A. Walsh
Bioethics Research Center Division of General Medicine and Geriatrics John T. Milliken Department of Medicine Washington University School of Medicine St. Louis Missouri USA
5 shared publications Emily E. Anderson
Neiswanger Institute for Bioethics, Loyola University of Chicago , Chicago , Illinois , USA
4 shared publicationsJean Campbell
3 shared publicationsElena Kraus
Bander Center for Medical Business Ethics , Saint Louis University
2 shared publicationsJeffrey M. Dueker
St Louis Univ, Dept Hlth Care Eth, 221 North Grand Blvd, St Louis, MO 63103 USA
2 shared publications
Latest Publications
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (2)
Editors’ Note
Narrative Inquiry in Bioethics would like to thank all of our new sponsors: the Bioethics Institute at [End Page v] Loyola Marymount University, the Neiswanger Institute for Bioethics at Loyola University Chicago, the Albert Gnaegi Center for Health Care Ethics at Saint Louis University, the Center for Humanities and Ethics at the University of Texas McGovern Medial School, the Bioethics Graduate Program and Center for Bioethics, Health and Society at Wake Forest University, and the Center for Clinical & Research Ethics at Washington University in St. Louis.
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (2)
Editors’ Note
Narrative Inquiry in Bioethics would like to thank all of our new sponsors: the Bioethics Institute at [End Page v] Loyola Marymount University, the Neiswanger Institute for Bioethics at Loyola University Chicago, the Albert Gnaegi Center for Health Care Ethics at Saint Louis University, the Center for Humanities and Ethics at the University of Texas McGovern Medial School, the Bioethics Graduate Program and Center for Bioethics, Health and Society at Wake Forest University, and the Center for Clinical & Research Ethics at Washington University in St. Louis.
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (1) , 79-80
Editors' Note
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (1) , 79-80
Editors' Note
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (1)
Editors' Note
For a list of current Calls for Stories and Author Guidelines, please visit http://nibjournal.org/submit/calls/. [End Page v]
- 1 January 2018
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 8 (1)
Editors' Note
For a list of current Calls for Stories and Author Guidelines, please visit http://nibjournal.org/submit/calls/. [End Page v]
- 1 January 2017
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 7 (3)
Editors’ Note
For a list of current Calls for Stories and Author Guidelines, please visit www.nibjournal.org. Our new website also includes a section on Education, which contains abstracts of all cases studies with discussion questions, a guide for facilitating narrative discussion groups, and a sample narrative discussion guide on the topic of stigma and bias in healthcare. We hope that these materials will assist those who facilitate learning with health care professionals and laypeople using the stories and cases published in NIB. [End Page v]
- 1 January 2017
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 7 (3)
Editors’ Note
For a list of current Calls for Stories and Author Guidelines, please visit www.nibjournal.org. Our new website also includes a section on Education, which contains abstracts of all cases studies with discussion questions, a guide for facilitating narrative discussion groups, and a sample narrative discussion guide on the topic of stigma and bias in healthcare. We hope that these materials will assist those who facilitate learning with health care professionals and laypeople using the stories and cases published in NIB. [End Page v]
- 1 January 2017
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 7 (2)
Editors' Note
We are pleased to publish the second issue of volume seven of Narrative Inquiry in Bioethics (NIB). This symposium includes 15 personal narratives. There are 12 stories that appear in print and an additional three are available in the online supplement. The stories are from people who have faced a cancer diagnosis—either their own or their child's—where the treatment threatened future fertility. NIB co–editor in chief, Ana Iltis served as the narrative symposium editor for this issue. She, along with other members of the NIB editorial staff, wrote the call for stories and invited Teresa Woodruff, Bryan Sisk, and Becket Gremmels to write commentary articles on these narratives. The three are experts in ovarian biology and oncofertility, pediatric oncology and decision–making, and healthcare ethics, respectively.
- 1 January 2017
- Published by Project MUSE in Narrative Inquiry in Bioethics
- Vol. 7 (2)
Editors' Note
We are pleased to publish the second issue of volume seven of Narrative Inquiry in Bioethics (NIB). This symposium includes 15 personal narratives. There are 12 stories that appear in print and an additional three are available in the online supplement. The stories are from people who have faced a cancer diagnosis—either their own or their child's—where the treatment threatened future fertility. NIB co–editor in chief, Ana Iltis served as the narrative symposium editor for this issue. She, along with other members of the NIB editorial staff, wrote the call for stories and invited Teresa Woodruff, Bryan Sisk, and Becket Gremmels to write commentary articles on these narratives. The three are experts in ovarian biology and oncofertility, pediatric oncology and decision–making, and healthcare ethics, respectively.
- Open Access
- 3 September 2013
- Published by Taylor & Francis in Accountability in Research
- Vol. 20 (5-6) , 320-338
Understanding Research Misconduct: A Comparative Analysis of 120 Cases of Professional Wrongdoing
We analyzed 40 cases of falsification, fabrication, or plagiarism (FFP), comparing them to other types of wrongdoing in research (n = 40) and medicine (n = 40). Fifty-one variables were coded from an average of 29 news or investigative reports per case. Financial incentives, oversight failures, and seniority correlate significantly with more serious instances of FFP. However, most environmental variables were nearly absent from cases of FFP and none were more strongly present in cases of FFP than in other types of wrongdoing. Qualitative data suggest FFP involves thinking errors, poor coping with research pressures, and inadequate oversight. We offer recommendations for education, institutional investigations, policy, and further research.
- 3 September 2013
- Published by Taylor & Francis in Accountability in Research
- Vol. 20 (5-6) , 320-338
Open AccessUnderstanding Research Misconduct: A Comparative Analysis of 120 Cases of Professional Wrongdoing
We analyzed 40 cases of falsification, fabrication, or plagiarism (FFP), comparing them to other types of wrongdoing in research (n = 40) and medicine (n = 40). Fifty-one variables were coded from an average of 29 news or investigative reports per case. Financial incentives, oversight failures, and seniority correlate significantly with more serious instances of FFP. However, most environmental variables were nearly absent from cases of FFP and none were more strongly present in cases of FFP than in other types of wrongdoing. Qualitative data suggest FFP involves thinking errors, poor coping with research pressures, and inadequate oversight. We offer recommendations for education, institutional investigations, policy, and further research.
- 22 July 2013
- Published by Taylor & Francis in AJOB Primary Research
- Vol. 4 (3) , 39-48
Understanding the Severity of Wrongdoing in Health Care Delivery and Research: Lessons Learned From a Historiometric Study of 100 Cases
Wrongdoing among physicians and researchers causes myriad problems for patients and research participants. While many articles have been published on professional wrongdoing, our literature review found no studies that examined the rich contextual details of large sets of historical cases of wrongdoing. We examined 100 cases of wrongdoing in healthcare delivery and research using historiometric methods, which involve the statistical description and analysis of coded historical narratives. We used maximum variation, criterion-based sampling to identify cases involving 29 kinds of wrongdoing contained in a taxonomy of wrongdoing developed for the project. We coded the presence of a variety of environmental and wrongdoer variables and rated the severity of wrongdoing found in each case. This approach enabled us to (a) produce rich descriptions of variables characterizing cases; (b) identify factors influencing the severity of wrongdoing; and (c) test the hypothesis that professional wrongdoing is a unified, relatively homogenous phenomenon such as “organizational deviance.” Some variables were consistently found across cases (e.g., wrongdoers were male and cases lasted more than 2 years), and some variables were consistently absent across cases (e.g., cases did not involve wrongdoers who were mistreated by institutions or penalized for doing what is right). However, we also found that some variables associated with wrongdoing in research (such as ambiguous legal and ethical norms) differ from those associated with wrongdoing in healthcare delivery (such as wrongdoers with a significant history of professional misbehavior). Earlier intervention from colleagues might help prevent the pattern we observed of repeated wrongdoing across multiple years. While some variables characterize the vast majority of highly publicized cases of wrongdoing in healthcare delivery and research—regardless of the kind of wrongdoing—it is important to examine and compare sets of relatively homogenous cases in order to identify factors associated with wrongdoing.
- 22 July 2013
- Published by Taylor & Francis in AJOB Primary Research
- Vol. 4 (3) , 39-48
Understanding the Severity of Wrongdoing in Health Care Delivery and Research: Lessons Learned From a Historiometric Study of 100 Cases
Wrongdoing among physicians and researchers causes myriad problems for patients and research participants. While many articles have been published on professional wrongdoing, our literature review found no studies that examined the rich contextual details of large sets of historical cases of wrongdoing. We examined 100 cases of wrongdoing in healthcare delivery and research using historiometric methods, which involve the statistical description and analysis of coded historical narratives. We used maximum variation, criterion-based sampling to identify cases involving 29 kinds of wrongdoing contained in a taxonomy of wrongdoing developed for the project. We coded the presence of a variety of environmental and wrongdoer variables and rated the severity of wrongdoing found in each case. This approach enabled us to (a) produce rich descriptions of variables characterizing cases; (b) identify factors influencing the severity of wrongdoing; and (c) test the hypothesis that professional wrongdoing is a unified, relatively homogenous phenomenon such as “organizational deviance.” Some variables were consistently found across cases (e.g., wrongdoers were male and cases lasted more than 2 years), and some variables were consistently absent across cases (e.g., cases did not involve wrongdoers who were mistreated by institutions or penalized for doing what is right). However, we also found that some variables associated with wrongdoing in research (such as ambiguous legal and ethical norms) differ from those associated with wrongdoing in healthcare delivery (such as wrongdoers with a significant history of professional misbehavior). Earlier intervention from colleagues might help prevent the pattern we observed of repeated wrongdoing across multiple years. While some variables characterize the vast majority of highly publicized cases of wrongdoing in healthcare delivery and research—regardless of the kind of wrongdoing—it is important to examine and compare sets of relatively homogenous cases in order to identify factors associated with wrongdoing.
- 1 July 2013
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 88 (7) , 924-928
A Humble Task
Virtues define how we behave when no one else is watching; accordingly, they serve as a bedrock for professional self-regulation, particularly at the level of the individual physician. From the time of William Osler through the end of the 20th century, physician virtue was viewed as an important safeguard for patients and research participants. However, the Institute of Medicine, Association of American Medical Colleges, and other policy groups—relying on social science data indicating that ethical decisions often result from unconscious and biased processes, particularly in the face of financial conflicts of interest—have increasingly rejected physician virtue as an important safeguard for patients. The authors argue that virtue is still needed in medicine—at least as a supplement to regulatory solutions (such as mandatory disclosures). For example, although rarely treated as a reportable conflict of interest, standard fee-for-service medicine can present motives to prioritize self-interest or institutional interests over patient interests. Because conflicts of interest broadly construed are ubiquitous, physician self-regulation (or professional virtue) is still needed. Therefore, the authors explore three strategies that physicians can adopt to minimize the influence of self-serving biases when making medical business ethics decisions. They further argue that humility must serve as a crowning virtue—not a meek humility but, rather, a courageous willingness to recognize one’s own limitations and one’s need to use “compensating strategies,” such as time-outs and consultation with more objective others, when making decisions in the face of conflicting interests.
- 1 July 2013
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 88 (7) , 924-928
A Humble Task
Virtues define how we behave when no one else is watching; accordingly, they serve as a bedrock for professional self-regulation, particularly at the level of the individual physician. From the time of William Osler through the end of the 20th century, physician virtue was viewed as an important safeguard for patients and research participants. However, the Institute of Medicine, Association of American Medical Colleges, and other policy groups—relying on social science data indicating that ethical decisions often result from unconscious and biased processes, particularly in the face of financial conflicts of interest—have increasingly rejected physician virtue as an important safeguard for patients. The authors argue that virtue is still needed in medicine—at least as a supplement to regulatory solutions (such as mandatory disclosures). For example, although rarely treated as a reportable conflict of interest, standard fee-for-service medicine can present motives to prioritize self-interest or institutional interests over patient interests. Because conflicts of interest broadly construed are ubiquitous, physician self-regulation (or professional virtue) is still needed. Therefore, the authors explore three strategies that physicians can adopt to minimize the influence of self-serving biases when making medical business ethics decisions. They further argue that humility must serve as a crowning virtue—not a meek humility but, rather, a courageous willingness to recognize one’s own limitations and one’s need to use “compensating strategies,” such as time-outs and consultation with more objective others, when making decisions in the face of conflicting interests.
- 1 December 2012
- Published by American Public Health Association in American Journal of Public Health
- Vol. 102 (12) , 2220-2225
Restoring Balance: A Consensus Statement on the Protection of Vulnerable Research Participants
A diverse panel convened in June 2011 to explore a dilemma in human research: some traits may make individuals or communities particularly vulnerable to a variety of harms in research; however, well-intended efforts to protect these vulnerable individuals and communities from harm may actually generate a series of new harms.We have presented a consensus statement forged by the panel through discussion during a 2-day meeting and the article-writing process.We have identified practical problems that sometimes arise in connection with providing additional safeguards for groups labeled as vulnerable and offered recommendations on how we might better balance concerns for protection with concerns for justice and participant autonomy.
- 1 December 2012
- Published by American Public Health Association in American Journal of Public Health
- Vol. 102 (12) , 2220-2225
Restoring Balance: A Consensus Statement on the Protection of Vulnerable Research Participants
A diverse panel convened in June 2011 to explore a dilemma in human research: some traits may make individuals or communities particularly vulnerable to a variety of harms in research; however, well-intended efforts to protect these vulnerable individuals and communities from harm may actually generate a series of new harms.We have presented a consensus statement forged by the panel through discussion during a 2-day meeting and the article-writing process.We have identified practical problems that sometimes arise in connection with providing additional safeguards for groups labeled as vulnerable and offered recommendations on how we might better balance concerns for protection with concerns for justice and participant autonomy.